In corporate governance news, Bryan Supran, a Non-Executive Director representing Pfizer (NYSE:PFE), has stepped down from Haleon’s board following Pfizer’s reduction of its stake in the ...

Pfizer to sell $3 billion stake in Sensodyne maker Haleon Pfizer will sell shares worth 2.50 billion pounds ($3.05 billion) in Haleon , lowering its stake in the British consumer healthcare ...

Realty Income has a solid strategy. It largely caters to companies in non-discretionary, service-oriented, non-retail, and ...

Pfizer sold 700 million ordinary shares of its investment in Haleon for approximately $3.0 billion, which brings down its stake in Haleon from approximately 15% to approximately 7%. Currently ...

Haleon HLN-1.12%decrease ... The consumer-health giant, which was spun out of GSK and is partly owned by Pfizer, said Thursday that it made a pretax profit of 1.91 billion pounds ($2.42 billion ...

In this article, we are going to take a look at where Haleon plc (NYSE:HLN) stands against other stocks that lead Monday’s charge amid market bloodbath. The stock market kicked off the trading ...

RBC Capital analyst James Edwardes Jones raised the firm’s price target on Haleon (HLN) to 370 GBp from 350 GBp and keeps a Sector Perform ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Shares of Haleon PLC HLN advanced 3.06% to £4.11 Monday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0.70% to 8,871.31.

Pfizer has also increased its dividend for 16 ... from the company's sale of its stake in British pharmaceutical company Haleon. Management also seems confident on its cash-flow generating ...